BOURNE GALLETLY PRACTICE TEAM — All Prescriptions & Medications — Page 3
Practice Code: C83054 | BOURNE, PE10 9BT
Showing results 101-150 of 732
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Progesterone | 828 | 46.8K | £8.8K | +97.8% ▲ |
| Ferrous fumarate | 818 | 39.0K | £1.2K | +12.9% ▲ |
| Combined ethinylestradiol 20mcg | 814 | 53.6K | £6.5K | +1,458.3% ▲ |
| Hydroxocobalamin | 810 | 1,054 | £2.4K | +68.3% ▲ |
| Levetiracetam | 790 | 78.6K | £6.7K | +72.6% ▲ |
| Estradiol | 780 | 18.7K | £8.5K | +189.1% ▲ |
| Duloxetine hydrochloride | 771 | 23.1K | £2.6K | +21.3% ▲ |
| Lactulose | 770 | 452.2K | £4.1K | +133.9% ▲ |
| Bimatoprost | 729 | 11.0K | £6.8K | +390.4% ▲ |
| Trimethoprim | 710 | 21.9K | £1.0K | +247.5% ▲ |
| Perindopril erbumine | 700 | 17.9K | £1.7K | +31.9% ▲ |
| Mirabegron | 659 | 16.2K | £14.6K | +64.1% ▲ |
| Betamethasone valerate | 657 | 46.9K | £3.0K | +70.6% ▲ |
| Glyceryl trinitrate | 656 | 2,108 | £1.8K | +177.4% ▲ |
| Buprenorphine | 650 | 2,839 | £19.4K | +77.4% ▲ |
| Oxybutynin | 647 | 26.2K | £1.4K | +239.7% ▲ |
| 645 | 646 | £27.9K | +107.6% ▲ | |
| Escitalopram | 645 | 16.9K | £1.3K | +126.6% ▲ |
| Donepezil hydrochloride | 643 | 15.0K | £1.2K | +108.4% ▲ |
| 639 | 114.3K | £5.8K | +529.1% ▲ | |
| Ranolazine | 614 | 28.2K | £6.9K | +261.3% ▲ |
| Insulin glargine | 602 | 2,907 | £24.8K | +112.0% ▲ |
| 597 | 620 | £774 | +170.9% ▲ | |
| Mebeverine hydrochloride | 593 | 43.1K | £1.9K | +91.0% ▲ |
| Diazepam | 590 | 16.7K | £372 | +18.5% ▲ |
| Ispaghula husk | 574 | 28.4K | £4.8K | +335.8% ▲ |
| Bumetanide | 572 | 21.6K | £2.1K | +110.0% ▲ |
| Pantoprazole | 550 | 16.8K | £814 | +100.1% ▲ |
| Topiramate | 543 | 28.7K | £1.9K | +205.5% ▲ |
| Carvedilol | 532 | 21.4K | £738 | +368.8% ▲ |
| Betahistine hydrochloride | 523 | 42.6K | £1.7K | +119.1% ▲ |
| Pravastatin sodium | 522 | 13.5K | £637 | +60.7% ▲ |
| 521 | 64.2K | £2.7K | +297.6% ▲ | |
| Sodium valproate | 515 | 68.9K | £5.7K | +61.9% ▲ |
| Nifedipine | 506 | 22.1K | £5.3K | +170.0% ▲ |
| Lymecycline | 505 | 14.7K | £1.8K | +319.8% ▲ |
| Fluticasone propionate (Inhalation) | 504 | 544 | £12.1K | +30.2% ▲ |
| Fluticasone propionate (Nasal) | 502 | 510 | £5.1K | +244.8% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 494 | 16.2K | £1.7K | +223.4% ▲ |
| Methotrexate | 491 | 12.4K | £1.5K | +50.9% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 489 | 61.9K | £3.9K | +223.5% ▲ |
| 479 | 69.7K | £2.6K | +73.2% ▲ | |
| Canagliflozin | 477 | 12.9K | £15.5K | +232.2% ▲ |
| Cefalexin | 473 | 14.3K | £1.1K | +306.6% ▲ |
| Hyoscine butylbromide | 469 | 37.4K | £2.8K | +101.2% ▲ |
| Mesalazine (Systemic) | 469 | 46.8K | £22.4K | +95.8% ▲ |
| Clarithromycin | 467 | 12.9K | £2.1K | +90.3% ▲ |
| Methylphenidate hydrochloride | 465 | 22.4K | £13.0K | +80.1% ▲ |
| Cyclizine hydrochloride | 462 | 23.5K | £908 | +186.4% ▲ |
| Medroxyprogesterone acetate | 458 | 458 | £2.5K | +279.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.